has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
| Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration P. S. Vosler, C. S. Brennan, and J. Chen Molecular Neurobiology (2008) 38: 78 Link to Article |
||
| The role of regulatory T cells in multiple sclerosis Alla L Zozulya and Heinz Wiendl Nature Clinical Practice Neurology (2008) 4: 384 Link to Article |
||
| The Immunopathology of Multiple Sclerosis: An Overview Hans Lassmann, Wolfgang Brück, and Claudia F. Lucchinetti Brain Pathology (2007) 17: 210 Link to Article |
||
| Nach dem TGN1412-Zwischenfall C. K. Schneider and U. Kalinke Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2007) 50: 1213 Link to Article |
||
| Oral Disease-Modifying Treatments for Multiple Sclerosis Bernd C Kieseier and Heinz Wiendl CNS Drugs (2007) 21: 483 Link to Article |
||
| Treatment and treatment trials in multiple sclerosis Bernd C Kieseier, Heinz Wiendl, Bernhard Hemmer, and Hans-Peter Hartung Current Opinion in Neurology (2007) 20: 286???293 Link to Article |
||
| OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic
region OSP179–207 Nathali Kaushansky, Reut Hemo, Miriam Eisenstein, and Avraham Ben-Nun European Journal of Immunology (2007) 37: 2018 Link to Article |
||
| Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues Nathali Kaushansky, Rina Zilkha-Falb, Reut Hemo, Hans Lassman, Miriam Eisenstein, Aldema Sas, and Avraham Ben-Nun European Journal of Immunology (2007) 37: 3281 Link to Article |
||
| T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies Bettina Schreiner, Samantha L Bailey, and Stephen D Miller Expert Review of Clinical Immunology (2007) 3: 57 Link to Article |
||
| Does inflammation stimulate remyelination? Reinhard Hohlfeld Journal of Neurology (2007) 254: I47 Link to Article |
||
| Multiple sclerosis therapy: An update on recently finished trials C. Kleinschnitz, S. G. Meuth, O. Stüve, B. Kieseier, and H. Wiendl Journal of Neurology (2007) 254: 1473 Link to Article |
||
| CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE Samantha L Bailey, Bettina Schreiner, Eileen J McMahon, and Stephen D Miller Nature Immunology (2007) 8: 172 Link to Article |
||
| Contribution of peptides to multiple sclerosis research Maria Claudia Alcaro and Anna Maria Papini Biopolymers (2006) 84: 349 Link to Article |
||
| Toward biomarkers in multiple sclerosis: new advances Francesco Lolli, Paolo Rovero, Mario Chelli, and Anna Maria Papini Expert Review of Neurotherapeutics (2006) 6: 781 Link to Article |
||
| Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis Anne L. Astier, Gregory Meiffren, Samuel Freeman, and David A. Hafler Journal of Clinical Investigation (2006) 116: 3252 Link to Article |
||
| pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients
correlates with disease activity Giovanni Frisullo, Francesco Angelucci, Marcella Caggiula, Viviana Nociti, Raffaele Iorio, Agata Katia Patanella, Cristina Sancricca, Massimiliano Mirabella, Pietro Attilio Tonali, and Anna Paola Batocchi Journal of Neuroscience Research (2006) 84: 1027 Link to Article |
||
| Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis Hans-Peter Hartung, Bernd C. Kieseier, and Bernhard Hemmer Journal of Neurology (2005) 252: v30 Link to Article |
||
| Drug Insight: using monoclonal antibodies to treat multiple sclerosis Reinhard Hohlfeld and Hartmut Wekerle Nature Clinical Practice Neurology (2005) 1: 34 Link to Article |
||
| Vaccines: past, present and future Stanley A Plotkin Nature Medicine (2005) 10: S5 Link to Article |
||
| Genomics and new targets for multiple sclerosis Sergio E Baranzini and Jorge R Oksenberg Pharmacogenomics (2005) 6: 151 Link to Article |
||
| Clinical Add-on: Multiple sclerosis – clinical picture and therapeutic strategies Hartmut Lins Signal Transduction (2005) 5: 266 Link to Article |
||